Immunotherapy Success in Gynecologic Cancers Will Require a Refined Approach – Targeted Oncology
|
Immunotherapy Success in Gynecologic Cancers Will Require a Refined Approach
Targeted Oncology Though immunotherapy with PD-1/PD-L1 inhibitors has been slower to develop in gynecologic cancers than in several other solid tumors, researchers are eyeing next steps to advance this area of the field. Success with these agents in gynecologic cancers … |
